X-Spectra Flavoured Tablets for Large Dogs
Nchi: Ufaransa
Lugha: Kiingereza
Chanzo: HMA (Heads of Medicines Agencies)
Tabia za bidhaa
(SPC)
23-04-2013
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
febantel 525 mg, praziquantel 175 mg, pyrantel 175 mg
Inapatikana kutoka:
CEVA Animal Health
ATC kanuni:
QP52AA51
Dawa fomu:
Tablet
Kundi la matibabu:
praziquantel, combinations
Eneo la matibabu:
Dogs
Idhini ya tarehe:
2011-11-23
Tabia za bidhaa
AN: 00824/2012
Revised: February 2013
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
X-SPECTRA Flavoured tablets for medium and small dogs [UK]
CESTEM F tablets for dogs [FR]
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One tablet contains:
ACTIVE SUBSTANCES:
Febantel ................................................................................. 150 mg
Pyrantel (as embonate) .......................................................... 50 mg
Praziquantel ............................................................................. 50 mg
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Tablet.
Yellow brown, oval tablet with a score line on both sides.
The tablets can be divided into equal halves.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of mixed infections by cestodes and nematodes of the following
species:
Nematodes:
Ascarids:
_Toxocara canis_, _Toxascaris leonina _(adult and late immature
forms)_ _.
Hookworms: _Uncinaria stenocephala_, _Ancylostoma caninum _(adults).
Whipworms: _Trichuris vulpis _(adults).
Cestodes:
Tapeworms: _Echinococcus _species, _(E. Granulosus, E. Multilocularis), Taenia _
species (T. hydatigena, T. pisiformis, T. taeniformis), _Dipylidium caninum _(adult
and immature forms).
AN: 00824/2012
Revised: February 2013
Page 2 of 6
4.3
CONTRAINDICATIONS
Do not use in animals with a known sensitivity to the active ingredients or to any
of the excipients.
See section 4.7 below.
4.4 SPECIAL WARNINGS FOR EACH TARGET
Soma hati kamili
